709652-84-6 Usage
Description
7-Bromo-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-one is a heterocyclic compound characterized by the presence of a bromine atom at the 7th position and a pyrazinone ring fused with a pyridine ring. It is a derivative of pyrido[2,3-b]pyrazin-2(1H)-one, which is a bicyclic structure with a pyrazine and a pyridine ring. 7-Bromo-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-one has potential applications in various fields due to its unique chemical properties and structural features.
Uses
Used in Pharmaceutical Industry:
7-Bromo-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-one is used as an intermediate in the synthesis of heterocyclic compounds with potential antibacterial properties. Its unique structure and functional groups make it a valuable building block for the development of new drugs targeting bacterial infections.
In the study mentioned in the provided materials, 7-Bromo-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-one was utilized to prepare heterocyclic compounds with antibacterial activity. These compounds can be further optimized and developed into effective antibacterial agents to combat drug-resistant bacteria and address the growing need for new antimicrobial therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 709652-84-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,9,6,5 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 709652-84:
(8*7)+(7*0)+(6*9)+(5*6)+(4*5)+(3*2)+(2*8)+(1*4)=186
186 % 10 = 6
So 709652-84-6 is a valid CAS Registry Number.
709652-84-6Relevant articles and documents
HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND METHOD USING THE SAME
-
, (2019/01/10)
The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosis. Formula (I) is shown below:
HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY
-
Page 189, (2010/02/07)
In part, the present invention is directed to antibacterial compounds of formula (I) wherein A is a bicyclic heteroaryl ring or a tricyclic ring and R2 is an heterocyclic residue; L is a bond, or L is alkyl, alkenyl or cycloalkyl.